Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Congenital chromosomal disease
|
47 | 0.570 | 0.480 | 3 | 14145949 | missense variant | G/T | snv | 0.63 | 0.65 | 0.020 | 1.000 | 2 | 2004 | 2012 | ||||
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C
|
82 | 0.570 | 0.480 | 3 | 14145949 | missense variant | G/T | snv | 0.63 | 0.65 | 0.100 | 0.875 | 16 | 2005 | 2019 | ||||
Carcinoma of bladder
|
309 | 0.570 | 0.480 | 3 | 14145949 | missense variant | G/T | snv | 0.63 | 0.65 | 0.100 | 1.000 | 11 | 2005 | 2016 | ||||
Malignant neoplasm of urinary bladder
|
316 | 0.570 | 0.480 | 3 | 14145949 | missense variant | G/T | snv | 0.63 | 0.65 | 0.100 | 1.000 | 11 | 2005 | 2016 | ||||
Bladder Neoplasm
|
281 | 0.570 | 0.480 | 3 | 14145949 | missense variant | G/T | snv | 0.63 | 0.65 | 0.090 | 1.000 | 9 | 2005 | 2016 | ||||
Carcinoma of lung
|
1204 | 0.570 | 0.480 | 3 | 14145949 | missense variant | G/T | snv | 0.63 | 0.65 | 0.070 | 1.000 | 7 | 2005 | 2019 | ||||
Malignant neoplasm of lung
|
1142 | 0.570 | 0.480 | 3 | 14145949 | missense variant | G/T | snv | 0.63 | 0.65 | 0.070 | 1.000 | 7 | 2005 | 2019 | ||||
Primary malignant neoplasm of lung
|
981 | 0.570 | 0.480 | 3 | 14145949 | missense variant | G/T | snv | 0.63 | 0.65 | 0.070 | 1.000 | 7 | 2005 | 2019 | ||||
Carcinoma, Small Cell
|
7 | 0.570 | 0.480 | 3 | 14145949 | missense variant | G/T | snv | 0.63 | 0.65 | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||
Small cell carcinoma of lung
|
125 | 0.570 | 0.480 | 3 | 14145949 | missense variant | G/T | snv | 0.63 | 0.65 | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||
Transitional cell carcinoma of bladder
|
158 | 0.570 | 0.480 | 3 | 14145949 | missense variant | G/T | snv | 0.63 | 0.65 | 0.010 | 1 | 2005 | 2005 | |||||
Colorectal Carcinoma
|
1962 | 0.570 | 0.480 | 3 | 14145949 | missense variant | G/T | snv | 0.63 | 0.65 | 0.090 | 0.889 | 9 | 2007 | 2018 | ||||
Malignant neoplasm of prostate
|
1082 | 0.570 | 0.480 | 3 | 14145949 | missense variant | G/T | snv | 0.63 | 0.65 | 0.050 | 0.800 | 5 | 2007 | 2019 | ||||
Prostate carcinoma
|
1168 | 0.570 | 0.480 | 3 | 14145949 | missense variant | G/T | snv | 0.63 | 0.65 | 0.050 | 0.800 | 5 | 2007 | 2019 | ||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.570 | 0.480 | 3 | 14145949 | missense variant | G/T | snv | 0.63 | 0.65 | 0.040 | 0.750 | 4 | 2007 | 2014 | ||||
Xeroderma pigmentosum, group F
|
31 | 0.570 | 0.480 | 3 | 14145949 | missense variant | G/T | snv | 0.63 | 0.65 | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||
Xeroderma pigmentosum, group G
|
31 | 0.570 | 0.480 | 3 | 14145949 | missense variant | G/T | snv | 0.63 | 0.65 | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||
Breast Carcinoma
|
2793 | 0.570 | 0.480 | 3 | 14145949 | missense variant | G/T | snv | 0.63 | 0.65 | 0.040 | 1.000 | 4 | 2008 | 2016 | ||||
Malignant neoplasm of breast
|
3417 | 0.570 | 0.480 | 3 | 14145949 | missense variant | G/T | snv | 0.63 | 0.65 | 0.040 | 1.000 | 4 | 2008 | 2016 | ||||
Malignant Neoplasms
|
1641 | 0.570 | 0.480 | 3 | 14145949 | missense variant | G/T | snv | 0.63 | 0.65 | 0.030 | 1.000 | 3 | 2008 | 2014 | ||||
Primary malignant neoplasm
|
1374 | 0.570 | 0.480 | 3 | 14145949 | missense variant | G/T | snv | 0.63 | 0.65 | 0.030 | 1.000 | 3 | 2008 | 2014 | ||||
Nasopharyngeal carcinoma
|
320 | 0.570 | 0.480 | 3 | 14145949 | missense variant | G/T | snv | 0.63 | 0.65 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Squamous cell carcinoma of esophagus
|
329 | 0.570 | 0.480 | 3 | 14145949 | missense variant | G/T | snv | 0.63 | 0.65 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Azoospermia
|
70 | 0.570 | 0.480 | 3 | 14145949 | missense variant | G/T | snv | 0.63 | 0.65 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Carcinoma of urinary bladder, superficial
|
6 | 0.570 | 0.480 | 3 | 14145949 | missense variant | G/T | snv | 0.63 | 0.65 | 0.010 | 1.000 | 1 | 2009 | 2009 |